The Australian pharmaceutical company Mayne Pharma announced on Thursday that it has launched a case in a U.S. court alleging patent infringement against Sun Pharma, an Indian company.
IMVEXXY is a vaginal insert designed to lessen pain during sexual activity after menopause. Mayne Pharma sued its rival alleging that the competitor had violated all 20 Orange Book-listed patents. The complaint was filed in the United States District Court for New Jersey.
Patents approved by the U.S. Food and Drug Administration (FDA) and considered safe for use are recorded in the Orange Book.
The Australian pharmaceutical company said that it was prompted to initiate the action by notice that Sun Pharma had submitted an Abbreviated New Drug Application (ANDA) to the FDA in an attempt to obtain permission to sell a generic version of IMVEXXY.
For feedback and suggestions, write to us at editorial@iifl.com
Related Tags
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Securities Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2024, IIFL Securities Ltd. All Rights Reserved
www.indiainfoline.com is part of the IIFL Group, a leading financial services player and a diversified NBFC. The site provides comprehensive and real time information on Indian corporates, sectors, financial markets and economy. On the site we feature industry and political leaders, entrepreneurs, and trend setters. The research, personal finance and market tutorial sections are widely followed by students, academia, corporates and investors among others.
Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
Invest wise with Expert advice
